Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix

NCT03202381 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Collaborators

[object Object]